Write a reviewFor vendors
♡
Home / Investors / Mark Krul

Mark Krul

Venture Fund · Amsterdam

About Mark Krul

Venture capital investor (Chief Scientific Officer) based in Amsterdam, The Netherlands. Focus areas include Health Care, Drug Discovery, Wellness. Invests at seed stage. Past investments include Immunogenik, Inc., Aglaia Oncology Fund II, Cristal Therapeutics.

Investment focus

Stages
Seed
Sectors
Health CareDrug DiscoveryWellnessEnterprise SoftwarePredictive AnalysisEngineeringInformation Technology (IT)3D TechnologyManufacturingBiotechnologyDrug DevelopmentFinTechResearchConsumer SoftwarePersonalized MedicineMedicalInformation TechnologyB2BTherapeuticsCellular Therapy

Portfolio

No portfolio companies recorded yet; Mark Krul reports 12 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Nash

Angel Investor · Los Altos
SeedPre-SeedAdvertisingData IntegrationTelecommunicationsE-commerce+16
60Investments
—Exits